HMOX1 and alkaline phosphatase measurement: These findings highlight the potential of TMPZ as a therapeutic agent for AP, suggesting that its beneficial effects may stem from modulating the NRF2/HO-1 pathway to inhibit pyroptosis and inflammation, offering a promising approach for the treatment of AP and other inflammatory conditions.